SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-012737
Filing Date
2016-02-16
Accepted
2016-02-16 06:05:24
Documents
67
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q nvet-10q_20151231.htm 10-Q 2167045
2 EX-31.1 nvet-ex311_9.htm EX-31.1 9785
3 EX-31.2 nvet-ex312_6.htm EX-31.2 9477
4 EX-32.1 nvet-ex321_7.htm EX-32.1 7630
5 EX-32.2 nvet-ex322_8.htm EX-32.2 7631
  Complete submission text file 0001564590-16-012737.txt   7829039

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT nvet-20151231.xml EX-101.INS 1876141
7 XBRL TAXONOMY EXTENSION SCHEMA nvet-20151231.xsd EX-101.SCH 52036
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nvet-20151231_cal.xml EX-101.CAL 40491
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nvet-20151231_def.xml EX-101.DEF 157092
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE nvet-20151231_lab.xml EX-101.LAB 376372
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nvet-20151231_pre.xml EX-101.PRE 295739
Mailing Address UNIT 5, SRAGH TECHNOLOGY PARK RAHAN ROAD TULLAMORE , CO. OFFALY L2 R35 FR98
Business Address UNIT 5, SRAGH TECHNOLOGY PARK RAHAN ROAD TULLAMORE , CO. OFFALY L2 R35 FR98 353 1 215 8100
Nexvet Biopharma plc (Filer) CIK: 0001618561 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-36828 | Film No.: 161422474
SIC: 2834 Pharmaceutical Preparations